Overview

Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD

Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
To assess the efficacy and safety of efficacy of MTS compared to placebo
Phase:
Phase 3
Details
Lead Sponsor:
Noven Therapeutics
Treatments:
Methylphenidate